Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H18O4 |
Molecular Weight | 202.2475 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCCCCCCCC(O)=O
InChI
InChIKey=CXMXRPHRNRROMY-UHFFFAOYSA-N
InChI=1S/C10H18O4/c11-9(12)7-5-3-1-2-4-6-8-10(13)14/h1-8H2,(H,11,12)(H,13,14)
Molecular Formula | C10H18O4 |
Molecular Weight | 202.2475 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | KLEER-PLEX ADVANCED ACNE CARE SYSTEM Approved UseAcne Treatment.
- For the management of acne.
- Clears up most acne pimples, blackheads, and whiteheads and allows skin to heal.
- Penetrates pores to eliminate most acne blemishes.
- Helps prevent new acne pimples. |
PubMed
Title | Date | PubMed |
---|---|---|
Use of even-numbered carbon atom dicarboxylic salts in parenteral nutrition as fuel substrate. | 1992 Jan-Feb |
|
Sebacic acid binding to human plasma albumin. | 1993 Feb 9 |
|
The lock-in phase in the urotropine-sebacic acid system. | 2001 Aug |
|
Urinary organic acids in peroxisomal disorders: a simple screening method. | 2001 Jul 5 |
|
In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition. | 2002 |
|
Pharmacokinetics of the carmustine implant. | 2002 |
|
Poly(glycerol sebacate) supports the proliferation and phenotypic protein expression of primary baboon vascular cells. | 2007 Dec 15 |
|
A QSPR for the plasticization efficiency of polyvinylchloride plasticizers. | 2008 Jan |
|
Sampling and analysis of nanoparticles with cold fibre SPME device. | 2009 Jun |
|
Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance. | 2009 Jun 11 |
|
Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro). | 2009 Mar |
|
Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice. | 2010 Dec |
|
μ-Decane-dioato-bis-[aqua-bis-(1,10-phenanthroline-κN,N')manganese(II)] dinitrate-sebacic acid-water (1/1/2). | 2010 Dec 15 |
|
Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting. | 2010 Nov 30 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:09:38 UTC 2023
by
admin
on
Fri Dec 15 15:09:38 UTC 2023
|
Record UNII |
97AN39ICTC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 78
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C011107
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
97AN39ICTC
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
DB07645
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
19492
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
SEBACIC ACID
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
5192
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
C84144
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
CONCEPT | Industrial Aid | ||
|
203-845-5
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
1427068
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID7026867
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
41865
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
111-20-6
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | |||
|
m9822
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY | Merck Index | ||
|
97AN39ICTC
Created by
admin on Fri Dec 15 15:09:38 UTC 2023 , Edited by admin on Fri Dec 15 15:09:38 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|